Physician profile
Robert Quiring
NPI 1386385656
$3,583.40
in general payments reported to CMS, 2019-2025
16 companies · $1,216 in 2025
The $1,216 reported for 2025 was more than what 90% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $93.99 · 2023: $680 · 2024: $1,593 · 2025: $1,216.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,394 · Education: $94.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,394.42 |
| Education | $94.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $588.00 | 2023-2025 | Skyrizi, Rinvoq |
| Lilly USA, LLC | $441.66 | 2024-2025 | Ebglyss, Taltz, Olumiant |
| Ucb, INC. | $412.82 | 2023-2025 | Bimzelx, Cimzia |
| Dermavant Sciences, INC. | $328.83 | 2023-2024 | Vtama |
| Novartis Pharmaceuticals Corporation | $314.31 | 2024-2025 | |
| Janssen Scientific Affairs, LLC | $272.04 | 2024 | Tremfya |
| Genzyme Corporation | $248.52 | 2025 | |
| Pfizer INC. | $158.86 | 2024-2025 | |
| Incyte Corporation | $139.75 | 2024 | |
| Janssen Biotech, INC. | $135.70 | 2024-2025 | Tremfya |
| Organon LLC | $126.75 | 2025 | Vtama |
| Regeneron Healthcare Solutions, INC. | $119.56 | 2022-2025 | Dupixent |
| Galderma Laboratories, L.P. | $101.09 | 2024 | Twyneo, Aklief |
| Mallinckrodt Hospital Products INC. | $91.56 | 2023 | Uvadex |
| Kyowa Kirin, INC. | $90.35 | 2023 | Poteligeo |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Botanix Sb INC | $13.60 | 2025 | Sofdra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Quiring listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.